Delivery Order SPE2DB20D3103-SPE2DB24FM5J9

Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ALPHAGAN P 0.15% eye drops in 5mL units. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $1,187.20 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,649.73 firm-fixed-price delivery order is for the supply of Alphagan P 0.15% eye drops, a pharmaceutical product. The contract has an ultimate completion date of February 29, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8ND3, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ALPHAGAN P 0.15% EYE DROPS 5ML, with a ceiling value of $1,153.40 and a completion date of May 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,263.60 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops in 5ml containers. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with a ceiling value of $1,203.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alphagan P 0.15% eye drops, a prescription medication, with a period of performance through January 21, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,534.92 firm fixed-price delivery order is for the procurement of ALPHAGAN P 0.1% DROPS 10ML, a pharmaceutical product. The ultimate completion date for this contract is February 9, 2024. The contract award is not designated as a set-aside and was made through full and open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, identified as SPE2DB20D3103 and SPE2DB22FN5K1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,694.95 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB43N, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ALPHAGAN P 0.15% EYE DROPS 5ML, with a ceiling value of $1,170.68 and a completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,281.62 firm-fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops, a medication used to treat glaucoma and high eye pressure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.04, is for the delivery of ALPHAGAN P 0.15% eye drops (10 mL) and is a firm fixed-price delivery order. The contract has an ultimate completion date of March 6, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM5J9
    Delivery Order

This federal contract award is for the delivery of ALPHAGAN P 0.15% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $3,052.45, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/14/25, 10:23 AM